AI Signal Dashboard
Last updated: 8 hours ago
Top Undervalued
+4.5¢
(No)
Will Integra Lifesciences (IART) beat quarterly earnings? AI analysis: • +4.5¢ undervalued • Live Prediction Market fair value & mispricing alerts.
Undervalued Options Insights:
The market price has surged to 89.5c, reflecting overwhelming confidence that Integra Lifesciences (...
🔓 Log in to see more
Real-time High Yield Opportunities
View MoreAll
Outcomes
Market
Price
AI Fair
Value
Value
Edge
YesNo
89.5¢
10.5¢
85¢
15¢
0¢
+4.5¢
⚠️ Risk Warning: Live data may lag! Prices can shift instantly due to news or low liquidity. Before trading, use AI Chat for [Live Recalculate], [Check Liquidity], [Trollbox Radar], or review [Fair Value Logic] to verify.
Hedging
IART
This event is directly tied to the earnings results of Integra Lifesciences (IART). Whether the earnings beat expectations will directly cause a moderate or higher fluctuation in IART's stock price (typically around 5% or more, depending on specifics), earning an impact score of 3. As a smaller-cap stock, its impact on the broader Russell 2000 index is negligible (score 1).
Movers
April 30, 2026 - May 1, 2026: The price of Option_'Yes' surged from 48c to 89.5c and sustained this high level, likely driven by strong market rumors or early guidance indicating an earnings beat, prompting aggressive one-sided bets ahead of the May 5 release.
April 29, 2026 - April 30, 2026: The price of Option_'Yes' spiked from 46.5c to 70c before settling back to 48c, likely due to short-term trading volatility or bets on an earnings beat.
April 27, 2026 - April 28, 2026: The price of Option_'Yes' rebounded from 17c to 50c, likely due to a market correction of the previous overreaction or the absorption of new forecast data.
April 26, 2026 - April 27, 2026: The price of Option_'Yes' crashed from 57.5c to 17c, potentially due to selling pressure from short-term negative speculation regarding the medical device sector or specific company fundamentals.